IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Abroad (travel likely)RecruitingPHASE3

Conditions

Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Third Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Yida Tang) · tang_yida@163.com · 010-82266699

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Abroad (travel likely)RecruitingPHASE3

Beijing, China · Beijing, China

Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days

Mixed Dyslipidemia · Hypercholesterolaemia

Abroad (travel likely)RecruitingPHASE3

Stockton-on-Tees, United Kingdom